Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces canc
Molecular Weight:
524.68
Purity:
99.97
CAS Number:
[936091-26-8]
Formula:
C27H36N6O3S
Target:
Apoptosis,JAK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted